EY Société d'Avocats is home to a highly experienced healthcare and life sciences team whose practice spans an array of industries, including medical devices, biopharmaceuticals, health insurance and research. The practice group is co-led by seasoned partners Virginie Lefebvre-Dutilleul, Guillaume Pezzali and Caroline Mercier-Havsteen. Lefebvre-Dutilleul advises on a wide array of strategic advisory and regulatory issues, from designing regulatory roadmaps to supply contracts. Pezzali strengthens the firm’s M&A capabilities, while Mercier-Havsteen excels in domestic and cross-border litigation, with specific expertise in product liability matters in the pharmaceutical sector.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Virginie Lefebvre-Dutilleul showcases excellent responsiveness, highly specialized technical knowledge, and pragmatism.’
- ‘EY Société d'Avocats is one of the strongest law firms in the EY Law global network. It has a broad and deep team who have been there for many years and have a great understanding of the value of multi-disciplinary services.'
- 'The firm is well served by a deep team of talented attorneys across the French practice.’
- ‘Virginie Lefebvre-Dutilleul is deeply connected with her clients, has a strong knowledge of the sector and as the leader of the legal transformation practice is constantly looking for ways to improve efficiency and service to clients.'
Key clients
- Octapharma
- Roquette
- Inserm and Inserm Transfert
- Servier Group
- Arthritis4Cure
- Association Inter AMC
- Regeneron Pharmaceuticals Inc.
- Merck KGaA
Work highlights
Advised a French regional health agency (ARS) on streamlining the radiology sector by coordinating over 30 radiology providers to enable the successful submission of a single establishment of medical licences (EML) application per geographical site.
Advised Regeneron Pharmaceuticals Inc. on implementing its entire regulatory, PV, and medical affairs infrastructure in Europe and globally in the context of the takeover of worldwide commercialization from Sanofi.
Advised Association Inter AMC on designing the contractual mechanisms and drafting the agreements for setting up a payment system allowing patients to avoid upfront payments to healthcare professionals.
Practice head
Virginie Lefebvre-Dutilleul; Guillaume Pezzali; Caroline Mercier-Havsteen